NCT03541369: Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia |
|
|
| Terminated | 1 | 64 | Europe, Canada, Japan, US, RoW | AMG 427, AMG 427; 20170528 | Amgen | Relapsed/Refractory Acute Myeloid Leukemia (AML) | 02/23 | 02/23 | | |